Damon Runyon Clinical Investigator Award 2027
The Damon Runyon Clinical Investigator Award, offered by the Damon Runyon Cancer Research Foundation in the United States, supports early-career physician-scientists at the Assistant Professor level conducting patient-oriented cancer research. This guide covers research areas consistent with the award, eligibility and readiness checks, what review panels typically value and how to prepare an application, submitted via Proposal Central with reference letters uploaded, by 19 January 2027.
The published deadline has passed. Check the official page in case it has been extended, or browse the open listings.
Key dates
- Application deadline
- 19 January 2027
- Details last checked
- 10 November 2026
About the call
- Funder
- Damon Runyon Cancer Research Foundation
- Country
- United States
- Scheme type
- Fellowship
- Funding
- As stated in the call documents
- Eligibility
- Early-career physician-scientists at the Assistant Professor level conducting patient-oriented cancer research; applications via Proposal Central with reference letters uploaded by the deadline.
- Scope
- Medicine and clinical research
Topics consistent with the call
- Early-phase clinical trials of new cancer therapies
- Biomarker studies guiding diagnosis, prognosis or treatment selection
- Translational studies using patient samples to investigate tumour biology
- Immunotherapy and mechanisms of treatment response or resistance
- Cancer prevention and early detection in patient populations
- Studies of treatment toxicity and supportive care in oncology
Based on the published scope; the official page sets out the full themes and requirements.
Is your work a fit? Check before you apply
- Confirm that you are a physician-scientist at the Assistant Professor level.
- Check that your project is patient-oriented cancer research.
- Arrange reference letters early so they are uploaded by the deadline.
- Confirm other eligibility rules, protected research time and award terms in the official guidelines.
- Submit a complete, institutionally approved application via Proposal Central before 19 January 2027.
Why This Funding Call Matters
Physician-scientists play a distinctive role in moving discoveries into patient care, but the early years of an academic appointment are often when clinical duties compete most strongly with research. Support at this stage helps investigators establish independent programmes in patient-oriented cancer research. The award is directed at this career point, and a successful application can provide the foundation for a sustained clinical research career and for later larger grants.
Who Should Apply
Academic backgrounds
- Medical oncology
- Haematology
- Radiation oncology
- Surgical oncology
- Paediatric oncology
Institutions and sectors
- Academic medical centres in the United States
- Comprehensive cancer centres
- University hospitals and medical schools
What Reviewers Typically Value
- A patient-oriented research question with clear potential to change cancer care.
- A feasible plan that builds on the applicant’s clinical access and preliminary data.
- Evidence of the applicant’s potential to become an independent clinical investigator.
- Strong mentorship and institutional commitment to protected research time.
Ideas You Could Develop
Your Plan to the Deadline
A suggested schedule working back from 19 January 2027. Adjust it to the stage your work has reached.
By 24 Nov 2026
Read the call documents; confirm eligibility, budget limits, assessment criteria and institutional requirements.
By 8 Dec 2026
Agree the research question, aims, team and partners; contact your research office.
By 22 Dec 2026
Draft the case for support, methods, impact and budget.
By 5 Jan 2027
Obtain internal review, letters of support and institutional sign-off.
By 14 Jan 2027
Final checks against the funder’s guidance and formatting rules.
By 19 Jan 2027
Submit through the funder’s system before the deadline.
What you gain
- Funding for the research, team and resources it needs.
- Recognition from a competitive, peer-reviewed process.
- Reviewer feedback that strengthens future applications.
- A track record for larger grants and fellowships.
What happens after you apply
- Eligibility check: the funder confirms the application meets the call rules.
- Peer review: external reviewers assess the proposal against the published criteria.
- Panel: a committee ranks proposals; some schemes include an interview.
- Decision: outcomes are released on the funder’s timetable.
- Award: successful applicants agree terms and reporting requirements before starting.
What the Funder Are Looking For
The foundation is looking for early-career physician-scientists at the Assistant Professor level who are conducting patient-oriented cancer research. Strong applications typically combine a clinically important question with a feasible research plan, strong mentorship and institutional support for protected time. Eligibility, award terms and submission requirements, including reference letters via Proposal Central, should be confirmed in the official Damon Runyon application guidelines.
Expert help
How Pubrica Can Help
Pubrica’s subject specialists can help you prepare a competitive proposal, planned back from the deadline. You remain the author of your work.
FAQs
Questions Researchers Ask
The next published deadline is 19 January 2027. Dates can change, so confirm them on the official page before you plan your work.
The award focuses on patient-oriented cancer research, and the foundation’s guidelines define what this includes. Laboratory work on patient samples may or may not qualify depending on that definition, so read the official guidelines carefully and contact the foundation if unsure.
Early-career physician-scientists at the Assistant Professor level conducting patient-oriented cancer research; applications via Proposal Central with reference letters uploaded by the deadline. Confirm the full eligibility rules in the call documents.
Yes. Pubrica’s specialists can review, write, edit and format your proposal. You remain the author and the person responsible for the submission.
Sources
- Damon Runyon Cancer Research Foundation. (2026). Damon Runyon Clinical Investigator Award 2027. Retrieved 10 November 2026, from https://www.damonrunyon.org/for-scientists/application-guidelines/clinical-investigator
How to cite this page
Pubrica Insights. (2026). Damon Runyon Clinical Investigator Award 2027. Pubrica. https://pubrica.com/insights/calls-and-conferences/damon-runyon-clinical-investigator-award-2027/
Pubrica Insights. “Damon Runyon Clinical Investigator Award 2027.” Pubrica, 2026, https://pubrica.com/insights/calls-and-conferences/damon-runyon-clinical-investigator-award-2027/.
Pubrica Insights (2026) Damon Runyon Clinical Investigator Award 2027. Pubrica. Available at: https://pubrica.com/insights/calls-and-conferences/damon-runyon-clinical-investigator-award-2027/ (Accessed: 10 November 2026).
Pubrica Insights. Damon Runyon Clinical Investigator Award 2027 [Internet]. Pubrica; 2026 [cited 2026 Nov 10]. Available from: https://pubrica.com/insights/calls-and-conferences/damon-runyon-clinical-investigator-award-2027/
Funding call